The Mdm network and its regulation of p53 activities: a rheostat of cancer risk.

Eischen CM, Lozano G
Hum Mutat. 2014 35 (6): 728-37

PMID: 24488925 · PMCID: PMC4725600 · DOI:10.1002/humu.22524

The potent transcriptional activity of p53 (Trp53, TP53) must be kept in check for normal cell growth and survival. Tumors, which drastically deviate from these parameters, have evolved multiple mechanisms to inactivate TP53, the most prevalent of which is the emergence of TP53 missense mutations, some of which have gain-of-function activities. Another important mechanism by which tumors bypass TP53 functions is via increased levels of two TP53 inhibitors, MDM2, and MDM4. Studies in humans and in mice reveal the complexity of TP53 regulation and the exquisite sensitivity of this pathway to small changes in regulation. Here, we summarize the factors that impinge on TP53 activity and thus cell death/arrest or tumor development.


MeSH Terms (13)

Animals Cell Cycle Checkpoints Cell Death Cell Proliferation Humans Mice Neoplasms Nuclear Proteins Proto-Oncogene Proteins Proto-Oncogene Proteins c-mdm2 Risk Factors Transcription, Genetic Tumor Suppressor Protein p53

Connections (1)

This publication is referenced by other Labnodes entities: